porphobilinogen has been researched along with Acquired Immunodeficiency Syndrome in 2 studies
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mouly, F | 1 |
| Janier, M | 1 |
| Nordmann, Y | 1 |
| Flageul, B | 1 |
| Fuchs, D | 1 |
| Artner-Dworzak, E | 1 |
| Hausen, A | 1 |
| Reibnegger, G | 1 |
| Werner, ER | 1 |
| Werner-Felmayer, G | 1 |
| Dierich, MP | 1 |
| Wachter, H | 1 |
2 other studies available for porphobilinogen and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
[Urinary porphyrin excretion in human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aminolevulinic Acid; Coproporphyrins; Female; HIV I | 1996 |
Urinary excretion of porphyrins is increased in patients with HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aminolevulinic Acid; Biopterins; Female; HIV | 1990 |